Finance

Lists
TELA:NASDAQ
TELA Bio Inc
US$1,14
0,00%
(0,00) 1D
US$1,11
-2,82% (-0,032)
After hours
Closed: 5 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TELA...
Open
US$1,16
High
US$1,20
Low
US$1,12
Mkt. cap
51,46 ລ້ານ
Avg. vol.
304,64 ພັນ
Volume
225,67 ພັນ
52-wk high
US$1,60
52-wk low
US$0,50
EPS
US$-0,77
Beta
1,36
Shares outstanding
45,14 ລ້ານ
No. of employees
218
Open
US$1,16
High
US$1,20
Low
US$1,12
Mkt. cap
51,46 ລ້ານ
Avg. vol.
304,64 ພັນ
Volume
225,67 ພັນ
52-wk high
US$1,60
52-wk low
US$0,50
EPS
US$-0,77
Beta
1,36
Shares outstanding
45,14 ລ້ານ
No. of employees
218
News stories
From web sources and news partners
TipRanks
TipRanks
·
15 ຊົ່ວໂມງກ່ອນ
TELA Bio gains FDA clearance for Liora scaffold
Investing.com UK
Investing.com UK
·
16 ຊົ່ວໂມງກ່ອນ
TELA Bio receives FDA clearance for resorbable mesh device By Investing.com
About TELA Bio Inc
CEO-
Employees218
Founded2012
HeadquartersMalvern, ເພນຊີນວາເນຍ, ສະຫະລັດ
SectorMedical device
Analyst ratings
Based on 4 analysts giving stock ratings to TELA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TELA in the last 3 months.
Highest
Current US$1,14
US$2,00 (+75,44%)
Average
US$1,75 (+53,51%)
Lowest
US$1,00 (-12,28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Frank Takkinen
Lake Street
Buy
Reiterated
US$2,00
+75,4%
09/30/2026
Chase Knickerbocker
Craig-Hallum
Buy
Initiated
US$2,00
+75,4%
09/25/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
US$2,00
+75,4%
08/31/2026
Matthew O'Brien
Piper Sandler
Hold
Maintained
US$1,00
-12,3%
08/11/2026
David Turkaly
Citizens JMP
Buy
Maintained
US$3,00
+163,2%
03/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
20,69 ລ້ານ
20,87 ລ້ານ
19,06 ລ້ານ
19,29 ລ້ານ
Cost of goods sold
6,62 ລ້ານ
7,02 ລ້ານ
6,44 ລ້ານ
5,25 ລ້ານ
Cost of revenue
6,62 ລ້ານ
7,02 ລ້ານ
6,44 ລ້ານ
5,25 ລ້ານ
Research and development expenses
2,35 ລ້ານ
2,13 ລ້ານ
2,34 ລ້ານ
2,72 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,18 ລ້ານ
18,27 ລ້ານ
20,70 ລ້ານ
20,50 ລ້ານ
Operating expense
21,62 ລ້ານ
20,50 ລ້ານ
23,14 ລ້ານ
23,32 ລ້ານ
Total operating expenses
28,24 ລ້ານ
27,52 ລ້ານ
29,58 ລ້ານ
28,57 ລ້ານ
Operating income
-7,55 ລ້ານ
-6,65 ລ້ານ
-10,53 ລ້ານ
-9,28 ລ້ານ
Other non operating income
152,00 ພັນ
277,00 ພັນ
366,00 ພັນ
157,00 ພັນ
EBT including unusual items
-8,60 ລ້ານ
-8,90 ລ້ານ
-12,21 ລ້ານ
-11,20 ລ້ານ
EBT excluding unusual items
-8,60 ລ້ານ
-8,01 ລ້ານ
-12,21 ລ້ານ
-11,20 ລ້ານ
Income tax expense
-
145,00 ພັນ
60,00 ພັນ
60,00 ພັນ
Effective tax rate
-
-1,63%
-0,49%
-0,54%
Other operating expenses
-
-
-
-
Net income
-8,60 ລ້ານ
-9,04 ລ້ານ
-12,27 ລ້ານ
-11,26 ລ້ານ
Net profit margin
-41,58%
-43,32%
-64,39%
-58,38%
Earnings per share
-0,19
-0,17
-0,21
-0,20
Interest and investment income
-
-
-
-
Interest expense
-1,20 ລ້ານ
-1,64 ລ້ານ
-2,05 ລ້ານ
-2,08 ລ້ານ
Net interest expenses
-1,20 ລ້ານ
-1,64 ລ້ານ
-2,05 ລ້ານ
-2,08 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,31 ລ້ານ
-6,42 ລ້ານ
-10,26 ລ້ານ
-9,02 ລ້ານ
Gain or loss from assets sale
-
-
18,00 ພັນ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google